Allergy and AsthmaNCT03539705
Food Allergy Registry at a Single Site
An observational study of Allergy and Asthma, run by Stanford University at 1 site in United States.
Trial summary
This is a registry of participants who are interested in being screened for clinical trials at a single site. Read more about this study
- Who is it for?
- Ages 0 to 100 years
- Conditions the study is for
- Allergy and Asthma
- How many people
- 6,000 participants
- Where
- 1 siteUnited States
- Study dates
- 5 Jan 2018to May 2028
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 0 to 100 years
- All sexes
- Child, Adult, Older adult
Study population: Any interested party from 0-100 yrs of age to enter their information in registry
Who may be able to join
- Any interested party from 0-100 yrs of age to enter their information in registry
Who cannot join
- Any individual who does not consent
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Stanford University
Palo Alto, California, 94304
Sharon Chinthrajah, MD, 650-521-7237, snpcenterallergy_inquiry@stanford.edu
About this study
This is a registry of participants who are interested in being screened for clinical trials at a single site.
Read the detailed description
This registry will be maintained on a secure database and will include demographics information such as name, gender, age, date of birth, ethnicity, race, and contact information, disease, medical information, other information (via questionnaires), and date of consent. It will be overseen by our data manager at our site and will not be shared with others outside of our site-specific trained individuals.
- Conditions
- Allergy and Asthma
- Being tested
- There is no intervention
- Medical subject headings
- Hypersensitivity, Asthma
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
There is no interventionOther
There is no intervention
What is being measured
The primary outcome is the main question the study is designed to answer.
Registry to provide a list of interested individuals in clinical trials at a single site
The clinical trials could be either allergy or asthma studies
Measured: 4 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 May 2018
- Study start5 Jan 2018
- Primary completionMay 2028 (estimated)
- Study completionMay 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Allergy and AsthmaStudies of the same condition, open and under way.
- More trials run by Stanford UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Other
- Enrolment
- 6,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Stanford University
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute of Allergy and Infectious Diseases (NIAID), Food Allergy Research & Education
- Responsible party
- Principal investigator, R. Sharon Chinthrajah, Stanford University
- Investigators
- Sharon Chinthrajah, Principal investigator, Stanford University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03539705
- Sponsor's protocol ID
- 36273
- Other IDs
- 1UM1AI130839-01, 1U01AI182039-01
- Status last verified
- Nov 2025
- First submitted
- 16 May 2018
- Last updated
- 14 Nov 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Nov 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Food Allergy Registry at a Single Site
- ClinicalTrials.gov ID
- NCT03539705
- Acronym / sponsor ID
- 36273
- Conditions
- Allergy and Asthma
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 6,000 participants (estimated)
- Lead sponsor
- Stanford UniversityUniversity, hospital or other
- Collaborators
- National Institute of Allergy and Infectious Diseases (NIAID), Food Allergy Research & Education
- Study start
- 5 Jan 2018 (actual)
- Primary completion
- May 2028 (estimated)
- Study completion
- May 2028 (estimated)
- First posted
- 29 May 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a registry of participants who are interested in being screened for clinical trials at a single site.
Detailed description
This registry will be maintained on a secure database and will include demographics information such as name, gender, age, date of birth, ethnicity, race, and contact information, disease, medical information, other information (via questionnaires), and date of consent. It will be overseen by our data manager at our site and will not be shared with others outside of our site-specific trained individuals.
Study design
- Observational model
- Other
- Time perspective
- Other
Who may qualify
- Ages
- 0 to 100 years
- Sex
- All
- Age groups
- Child, Adult, Older adult
- Study population
- Any interested party from 0-100 yrs of age to enter their information in registry
Key inclusion criteria (1 listed)
- Any interested party from 0-100 yrs of age to enter their information in registry
Key exclusion criteria (1 listed)
- Any individual who does not consent
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| There is no interventionThere is no intervention | Other | – |
Primary outcome
Registry to provide a list of interested individuals in clinical trials at a single site
Time frame: 4 years
The clinical trials could be either allergy or asthma studies
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Nov 2025.
- Individual participant dataSharing planned: No
Related trials for Allergy and Asthma
RecruitingPhase 1
Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation
Asthma
RecruitingPhase 1
A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive
Asthma, Mild Asthma
Active, not recruitingPhase 2/3
Local Antibiotic Delivery for Community Acquired Pneumonia
Community Acquired Pneumonia (CAP)
RecruitingPhase 2
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Asthma
Recruiting
THERMotherapy Against Persistent Bacterial LUNG Infections
Lung Diseases, Obstructive, Bronchiectasis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Sharon Chinthrajah principal investigator
Stanford University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Allergy and Asthma, run by Stanford University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 14 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact SNP Center Inquiry (650-521-7237, snpcenterallergy_inquiry@stanford.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Registry to provide a list of interested individuals in clinical trials at a single site (time frame: 4 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Nov 2025.